Logo of National Eczema Association mobile menu icon
Icon link to National Eczema's Instagram feed. Icon link to National Eczema's YouTube channel. Icon link to National Eczema's Facebook page. Icon link to National Eczema's Twitter feed. Icon link to National Eczema's inspire.com page. Search Icon to search the site

Get the tools and support you need to best manage your eczema

  • This field is for validation purposes and should be left unchanged.

Discoveries

Low-dose Naltrexone for atopic dermatitis?

Dermatologists discuss the potential efficacy of prescribing an opioid antagonist to address the problem of itch in atopic dermatitis.

Read More


AD topical cream Jakafi moving on to phase 3 clinical trial

A new, nonsteroidal topical cream for AD called Jakafi (ruxolitinib) may soon hit pharmacy shelves.

Read More


New biomarkers identified for pediatric AD

Does atopic dermatitis behave differently based on a person’s skin tone? Researchers at the University of Amsterdam are trying to find out.

Read More


Biologics may show greater risk for infection than systemics

Off-label use of biologic treatments for atopic dermatitis may double the risk for serious infection compared to systemic treatments, researchers found.

Read More


Microbiome-based atopic dermatitis treatment shows promise

A topical treatment containing a common “healthy” skin bacterium was found to reduce AD severity in adults and kids in an early-phase clinical trial.

Read More


5 new-ish complementary, alternative treatments for eczema

Honey, L-histidine, East Indian Sandalwood oil, vitamin E and melatonin are among the latest complementary and alternative treatments for eczema undergoing clinical research.

Read More


Mounting evidence sheds light on the burden of eczema

Atopic dermatitis is more than just financial burden on households. It has social, economic, academic and occupational repercussions as well, studies show.

Read More


Dupixent may soon be approved for teenagers

Dupixent, a biologic drug for moderate to severe AD, may soon be available to patients aged 12 to 18 if the treatment continues its success rate in adolescent clinical trials.

Read More


Clinical trials for eczema can change your life

Now that we’re in the “Era of Eczema,” it’s never been easier for patients to help researchers develop better treatments for atopic dermatitis.

Read More


Severe AD Linked to CV Risk

Prevention strategies can help reduce the risk of cardiovascular disease among patients with severe or predominately active AD, including awareness of and screening for conventional cardiovascular risk factors.

Read More